Literature DB >> 2705528

Rat liver metabolism of dicarboxylic acids.

J Vamecq1, J P Draye, J Brison.   

Abstract

Recently, we demonstrated in rat liver that dicarboxylic acids containing more than five carbons can be activated by a microsomal dicarboxylyl-CoA synthetase (J. Vamecq, E. de Hoffmann, and F. Van Hoof. Biochem. J. 230: 683-693, 1985). The products of this reaction, dicarboxylyl-CoA esters, were found to be substrates for an H2O2-generating dicarboxylyl-CoA oxidase. In the present work we report that 1) the catalytic center or the essential domains of dicarboxylyl-CoA synthetase are located at the cytosolic aspect of the endoplasmic reticulum membrane; 2) dicarboxylyl-CoA oxidase is optimally active on dodecanedioyl-CoA and is a peroxisomal enzyme; 3) cyanide-insensitive dodecanedioyl-CoA oxidation (NADH production) is catalyzed by rat liver homogenates. Cell fractionation studies disclose that, similar to dodecanedioyl-CoA oxidase (H2O2 production), the cyanide-insensitive dodecanedioyl-CoA oxidizing activity also belongs to peroxisomes; 4) a dodecanedioyl-CoA oxidoreductase reaction can be assayed by the dichlorphenolindophenol procedure in rat liver homogenates, and the activity is abundant in peroxisomal, mitochondrial, and soluble fractions; 5) by contrast with monocarboxylyl-CoA esters, the dicarboxylyl-CoAs are apparently not substrates for mitochondrial fatty acid oxidation; however, the use of dicarboxylylcarnitine esters as direct substrate for mitochondria suggests the existence of an active beta-oxidation of dicarboxylates in these organelles, which is further confirmed by experiments in which mitochondria are permeabilized with digitonin; 6) the in vivo oxidation of infused dodecanedioic acid results in a rapid appearance in urine of medium-chain dicarboxylic acids, with only 30-50% of the infused dose recovered in urine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705528     DOI: 10.1152/ajpgi.1989.256.4.G680

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids.

Authors:  Sander M Houten; Simone Denis; Carmen A Argmann; Yuzhi Jia; Sacha Ferdinandusse; Janardan K Reddy; Ronald J A Wanders
Journal:  J Lipid Res       Date:  2012-04-25       Impact factor: 5.922

Review 2.  Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.

Authors:  Sander M Houten; Ronald J A Wanders; Pablo Ranea-Robles
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-02-10       Impact factor: 5.187

3.  Compartmentation of Metabolism of the C12-, C9-, and C5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis: ANAPLEROSIS FROM DODECANEDIOATE.

Authors:  Zhicheng Jin; Fang Bian; Kristyen Tomcik; Joanne K Kelleher; Guo-Fang Zhang; Henri Brunengraber
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

Review 4.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

5.  Atypical riboflavin-responsive glutaric aciduria, and deficient peroxisomal glutaryl-CoA oxidase activity: a new peroxisomal disorder.

Authors:  M J Bennett; R J Pollitt; S I Goodman; D E Hale; J Vamecq
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

6.  Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.

Authors:  Asem I Fitian; David R Nelson; Chen Liu; Yiling Xu; Miguel Ararat; Roniel Cabrera
Journal:  Liver Int       Date:  2014-04-28       Impact factor: 5.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.